Las Vegas, NV -- (SBWIRE) -- 12/09/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: WidePoint Corporation (NYSEMKT:WYY), Real Goods Solar, Inc. (NASDAQ:RSOL), Cross Country Healthcare, Inc. (NASDAQ:CCRN), Generex Biotechnology Corporation (OTCMKTS:GNBT)
WidePoint Corporation (NYSEMKT:WYY) managed to keep its gain at 18.10% on above-normal volume of 2.06M shares. The stock settled at $1.24 after floating in a range of $1.04 to $1.28. Its latest price has reached market capitalization of $79.18 million. Its 52-week range has been $0.32 to $1.28. WidePoint Corporation (WidePoint) is a provider of customized technology-based products and solutions to both the government sector and commercial markets. The Company operates in three segments: Communications Management, Cybersecurity Solutions, and Consulting Services and Products. WidePoint, through its wholly owned subsidiaries iSYS LLC (iSYS) and WidePoint Solutions.
For How Long WYY will fight for Profitability? Read This Trend Analysis report
Real Goods Solar, Inc. (NASDAQ:RSOL) traded down on a volume of 2 million, lower than its standard daily volume. Shares have dropped-1.12% to $2.65. Over the last twelve months, the stock has gained 381.82% and faced a worst price of $0.50. Real Goods Solar, Inc. is a solar energy company serving the commercial, residential and utility customers. As of February 5, 2013, the Company had installed more than 14,500 solar power systems representing over 100 megawatts of 100% renewable energy.
Has RSOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Cross Country Healthcare, Inc. (NASDAQ:CCRN) settled -1.42% lower at $6.94 on above-normal volume of 1.98M shares during the last trading day. The stock has its 12-month high at $7.75 and 52-week low price was $4.32. It traded in a range of $6.33 to $7.12 during the last trading day. Cross Country Healthcare, Inc. (Cross Country) is engaged in the healthcare staffing services business offering a suite staffing and outsourcing services to the healthcare market. The Company segments include nurse and allied staffing, physician staffing, and other human capital management services.
Will CCRN Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Generex Biotechnology Corporation (OTCMKTS:GNBT) was down on high volume, trading at a volume of 1.88M versus its average daily volume of 1.86 million shares. At $0.0297, the stock has attained market capitalization of 17.24 million. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)